Tatton-Brown Katrina, Douglas Jenny, Coleman Kim, Baujat Genevieve, Cole Trevor R P, Das Soma, Horn Denise, Hughes Helen E, Temple I Karen, Faravelli Francesca, Waggoner Darrel, Turkmen Seval, Cormier-Daire Valerie, Irrthum Alexandre, Rahman Nazneen
Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom.
Am J Hum Genet. 2005 Aug;77(2):193-204. doi: 10.1086/432082. Epub 2005 Jun 7.
We identified 266 individuals with intragenic NSD1 mutations or 5q35 microdeletions encompassing NSD1 (referred to as "NSD1-positive individuals"), through analyses of 530 subjects with diverse phenotypes. Truncating NSD1 mutations occurred throughout the gene, but pathogenic missense mutations occurred only in functional domains (P < 2 x 10(-16)). Sotos syndrome was clinically diagnosed in 99% of NSD1-positive individuals, independent of the molecular analyses, indicating that NSD1 aberrations are essentially specific to this condition. Furthermore, our data suggest that 93% of patients who have been clinically diagnosed with Sotos syndrome have identifiable NSD1 abnormalities, of which 83% are intragenic mutations and 10% are 5q35 microdeletions. We reviewed the clinical phenotypes of 239 NSD1-positive individuals. Facial dysmorphism, learning disability, and childhood overgrowth were present in 90% of the individuals. However, both the height and head circumference of 10% of the individuals were within the normal range, indicating that overgrowth is not obligatory for the diagnosis of Sotos syndrome. A broad spectrum of associated clinical features was also present, the occurrence of which was largely independent of genotype, since individuals with identical mutations had different phenotypes. We compared the phenotypes of patients with intragenic NSD1 mutations with those of patients with 5q35 microdeletions. Patients with microdeletions had less-prominent overgrowth (P = .0003) and more-severe learning disability (P = 3 x 10(-9)) than patients with mutations. However, all features present in patients with microdeletions were also observed in patients with mutations, and there was no correlation between deletion size and the clinical phenotype, suggesting that the deletion of additional genes in patients with 5q35 microdeletions has little specific effect on phenotype. We identified only 13 familial cases. The reasons for the low vertical transmission rate are unclear, although familial cases were more likely than nonfamilial cases (P = .005) to carry missense mutations, suggesting that the underlying NSD1 mutational mechanism in Sotos syndrome may influence reproductive fitness.
通过对530名具有不同表型的受试者进行分析,我们鉴定出266名携带NSD1基因内突变或包含NSD1的5q35微缺失的个体(称为“NSD1阳性个体”)。截短型NSD1突变遍布整个基因,但致病性错义突变仅发生在功能域(P < 2×10⁻¹⁶)。99%的NSD1阳性个体临床诊断为索托斯综合征,与分子分析无关,这表明NSD1畸变基本上是这种疾病所特有的。此外,我们的数据表明,93%临床诊断为索托斯综合征的患者有可识别的NSD1异常,其中83%是基因内突变,10%是5q35微缺失。我们回顾了239名NSD1阳性个体的临床表型。90%的个体存在面部畸形、学习障碍和儿童期过度生长。然而,10%的个体身高和头围在正常范围内,这表明过度生长并非索托斯综合征诊断的必要条件。还存在广泛的相关临床特征,其出现很大程度上与基因型无关,因为具有相同突变个体的表型不同。我们比较了NSD1基因内突变患者与5q35微缺失患者的表型。与突变患者相比,微缺失患者的过度生长不那么明显(P = 0.0003),学习障碍更严重(P = 3×10⁻⁹)。然而,微缺失患者出现的所有特征在突变患者中也有观察到,并且缺失大小与临床表型之间没有相关性,这表明5q35微缺失患者中其他基因的缺失对表型几乎没有特异性影响。我们仅鉴定出13个家族病例。垂直传播率低的原因尚不清楚,尽管家族病例比非家族病例更有可能(P = 0.005)携带错义突变,这表明索托斯综合征潜在的NSD1突变机制可能影响生殖适应性。